Eli Lilly has developed artificial intelligence models that can help predict the behavior of potential drug candidates, based on the data the drugmaker has collected over the last two decades and at ...

Eli Lilly has partnered with Julianne Moore, tapping into the actor’s experience in the movie “Still Alice” to encourage people to prioritize brain health. Moore played the titular role in the film.

Sept 9 (Reuters) - Drugmaker Eli Lilly (LLY.N), opens new tab said on Tuesday it is launching an artificial intelligence and machine learning platform that provides biotech companies access to drug ...

A federal appeals court on Thursday rejected Eli Lilly’s appeal of an $183.7 million judgment won by a whistleblowing lawyer and pharmacist who accused the drugmaker of defrauding Medicaid. The 7th ...

If it obtains regulatory approval for its GLP-1 pill, that would be a huge catalyst ahead. The company already has injectable GLP-1 drugs that are generating billions in revenue, Despite its valuation ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said it has launched TuneLab, an artificial intelligence and machine learning (AI/ML) platform to provide biotechnology companies access to drug ...

I am bullish on Eli Lilly, despite recent underperformance and Orforglipron's clinical results falling short of high expectations. Eli Lilly's robust R&D, strong pipeline, and leadership in diabetes, ...

Eli Lilly has built a track record of growth thanks to a wide variety of drugs, but one portfolio in particular may drive gains a few years from now. The company already is a leader in the weight-loss ...

Sept 8 (Reuters) - Eli Lilly's (LLY.N), opens new tab approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients in a late-stage study, advancing ...

HOUSTON – Before the State of Harris County address, Greater Houston Partnership President & Chief Executive Officer Steve Kean said, “We’ve got a big one coming. Going to invest billions of dollars.” ...

Novo Nordisk (NVO) (OTCPK:NONOF) announced on Sunday that its popular weight loss drug Wegovy resulted in more than a 50% decrease in serious heart issues such as stroke compared to Eli Lilly’s ...

The U.S. Food and Drug Administration (FDA) on Thursday granted Breakthrough Therapy designation to Eli Lilly and Co.’s LLY olomorasib, in combination with Merck & Co. Inc.’s MRK anti-PD-1 therapy ...